Immediate Impact
1 from Science/Nature 52 standout
Citing Papers
Pancreatic cancer
2025 Standout
In Situ Rapid‐Formation Sprayable Hydrogels for Challenging Tissue Injury Management
2024 Standout
Works of Antonio Testa being referenced
Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Antonio Testa | 311 | 88 | 6 | 115 | 109 | 14 | 394 | |
| E. Bonetto | 394 | 71 | 155 | 176 | 15 | 450 | ||
| C. Bernard | 156 | 107 | 12 | 80 | 88 | 19 | 436 | |
| Catherine Jephcott | 318 | 166 | 2 | 164 | 120 | 10 | 438 | |
| Leslie D. Boucher | 232 | 42 | 16 | 86 | 50 | 13 | 373 | |
| Alberto Romero | 224 | 70 | 56 | 91 | 88 | 19 | 346 | |
| Romano Scalerta | 174 | 85 | 2 | 72 | 94 | 16 | 367 | |
| Martin Thoma | 222 | 109 | 2 | 101 | 113 | 13 | 374 | |
| Sheema Hassan | 153 | 82 | 51 | 52 | 15 | 343 | ||
| Michèle Natale | 290 | 45 | 2 | 255 | 32 | 25 | 410 | |
| Francesca Marcon | 253 | 220 | 1 | 96 | 58 | 21 | 416 |
All Works
Login with ORCID to disown or claim papers
Loading papers...